Review
Open access
Oct 2026
Window of Opportunity and Predictors of Sustained Remission in Patients with Hidradenitis Suppurativa Treated with Adalimumab: A 540-Patient Cohort Study
Lower BMI, early biologic intervention, and a limited baseline burden of tunnels are key predictors for achieving sustained remission off-drug, supporting a limited window of opportunity in HS.
E. Vilarrasa, P. Garbayo-Salmons, E. Masferrer et al.
· Dermatologic Therapy · 1 citation